Skip to main content
SpringerLink
Log in

Prise en charge du cancer du sein infiltrant de la femme âgée de 40 ans ou moins

  • Veille Bibliographique / Literature Monitoring
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Adami HO, Malker B, Holmberg L, et al. (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315: 559–563

    PubMed  CAS  Google Scholar 

  2. Adams E, McCann L, Armes J, et al. (2010) The experiences, needs and concerns of younger women with breast cancer: a meta-ethnography. Psycho-oncology: article first published online: 30 June 2010, DOI:10.1002/pon.1792

  3. Aebi S, Gelber S, Castiglione-Gertsch M, et al. (2000) Is chemotherapy alone adequate for young women with estrogen-receptor-positive breast cancer? Lancet 355: 1869–1874

    PubMed  CAS  Google Scholar 

  4. Agrup M, Stäl O, Olsen K, et al. (2000) C-erbB-2 overexpression and survival in early onset breast cancer. Breast Cancer Res Treat 63: 23–29

    PubMed  CAS  Google Scholar 

  5. Albain KS, Barlow WE, Shak S, et al. (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, estrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11: 55–65

    PubMed  CAS  Google Scholar 

  6. Albritton K, Barr R, Bleyer A (2009) The adolescence of yound adult oncology. Semin Oncol 36(5): 478–488

    PubMed  Google Scholar 

  7. Anders CK, Hsu DS, Broadwater G, et al. (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: 3324–3330

    PubMed  Google Scholar 

  8. Andre F, Khalil A, Slimane K, et al. (2005) Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer. J Clin Oncol 23: 2996–3000

    PubMed  CAS  Google Scholar 

  9. Ansquer Y, Gautier C, Fourquet A, et al. (1998) Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet 352: 541

    PubMed  CAS  Google Scholar 

  10. Ardern-Jones A, Kenen R, Eeles R (2005) Too much, too soon? Patients and Health professionals’ views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care 14: 272–281

    CAS  Google Scholar 

  11. Arora NK, Gustafson DH, Hawkins RP et al. (2001) Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer 92: 1288–1298

    PubMed  CAS  Google Scholar 

  12. Arriagada G, Lê MG, Contesso G, et al. (2002) Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13: 1404–1413

    PubMed  CAS  Google Scholar 

  13. Arriagada R, Lê MG, Spielmann M, et al. (2005) Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol 16(3): 389–396

    PubMed  CAS  Google Scholar 

  14. Arriagada R, Spielmann M, Koscielny S, et al. (2002) Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen. Ann Oncol 13: 1378–1386

    PubMed  CAS  Google Scholar 

  15. Ataya KM, McKanna JA, Weintraub AM, et al. (1985) A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res 45(8): 3651–3656

    PubMed  CAS  Google Scholar 

  16. Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26(16): 2630–2635

    PubMed  CAS  Google Scholar 

  17. Bauer KR, Brown M, Cress RD, et al. (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 109: 1721–1728

    PubMed  Google Scholar 

  18. Beadle BM, Woodward WA, Tucker SL, et al. (2009) Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 73(3): 734–744

    PubMed  Google Scholar 

  19. Ben-Aharon I, Gafter-Gvili A, Leibovici L, et al. (2010) Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 122(3): 803–811

    PubMed  Google Scholar 

  20. Berliere M, Dalenc F, Malingret N, et al. (2008) Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer 8: 56

    PubMed  Google Scholar 

  21. Berry DA, Cirrincione C, Henderson IC, et al. (2006) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. J Am Med Assoc 295: 1658–1667

    CAS  Google Scholar 

  22. Blakely LJ, Buzdar AU, Lozada JA, et al. (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100: 465–469

    PubMed  Google Scholar 

  23. Blamey RW, Hornmark-Stenstam B, Ball G, et al. (2010) ONCOPOOL — A European database for 16,944 cases of breast cancer. Eur J Cancer 46: 56–71

    PubMed  CAS  Google Scholar 

  24. Bloom JR, Stewart SL, Chang S, et al. (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13: 147–160

    PubMed  Google Scholar 

  25. Blumenfeld Z, Eckman A (2005) Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr (34): 40–43

    PubMed  CAS  Google Scholar 

  26. Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14(6): 543–552

    PubMed  CAS  Google Scholar 

  27. Bollet MA, Sigal-Zafrani B, Mazeau V, et al. (2007) Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (< 40 years) women treated with breast conserving surgery first. Radiother Oncol 82: 272–280

    PubMed  Google Scholar 

  28. Bossard N, Velten M, Remontet L, et al. (2007) Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43: 149–160

    PubMed  CAS  Google Scholar 

  29. Botteri E, Bagnardi V, Rotmensz N, et al. (2010) Analysis of local and regional redurrences in breast cancer after conservative surgery. Ann Oncol 21: 723–728

    PubMed  CAS  Google Scholar 

  30. Brennan ME, Houssami N, Lord S, et al. (2009) Magnetic resonnance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incermental cancer detection and impact on surgical management. C Clin Oncol 27: 5640–5649

    Google Scholar 

  31. Brinton LA, Sherman ME, Carreon JD, et al. (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100: 1643–1648

    PubMed  Google Scholar 

  32. Burgess C, Cornelius V, Love S, et al. (2005) Depression and anxiety in woman with early breast cancer: five years observational cohort study. BMJ 330(7493): 702

    PubMed  Google Scholar 

  33. Burwel SR, Case LD, Kaelin C, et al. (2006) Sexual problems younger women after breast cancer surgery. J Clin Oncol 24: 2815–2821

    Google Scholar 

  34. Cancello G, Maisonneuve P, Rotmensz N, et al. (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (< 35 years) with operable breast cancer. Ann Oncol 21: 1974–1981

    PubMed  CAS  Google Scholar 

  35. Carlson RW, Allred DC, Anderson BO, et al. (2009) NCCN Breast Cancer Clinical Practice Guidelines Panel. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7(2): 122–192

    PubMed  CAS  Google Scholar 

  36. Cayrou S, Dickes P (2008) Les facteurs associés à l’ajustement mental des malades du cancer: un exemple d’utilisation de la MAC. Chapitre IV: Les problèmes psychologiques des malades et leur prise en charge — Étude DRESS: La vie deux ans après le diagnostic de cancer — Le Corroler-Soriano AG, Malatvolti L, Mermilliod C. Ministère du Travail

  37. Chabert Buffet N, Uzan C, Gligorov J, et al. (2010) Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy. Surg Oncol 19(1): e47–e55. Epub 2009 May 14

    Google Scholar 

  38. Chia S, Bryce C, Gelmon K (2005) The 2000 EBCTCG overview: a widening gap. Lancet 365(9472): 1665–1666

    PubMed  CAS  Google Scholar 

  39. Chung M, Chang HR, Bland KI, et al. (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97–103

    PubMed  CAS  Google Scholar 

  40. Cimprich B, Ronis DL, Martnez-Ramos G (2002) Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract 10: 85–93

    PubMed  Google Scholar 

  41. Colleoni M, Rotmensz N, Robertson C, et al. (2002) Very young women (< 35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13: 273–279

    PubMed  CAS  Google Scholar 

  42. Conforti R, Boulet T, Tomasic G, et al. (2007) Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol 18: 1477–1483

    PubMed  CAS  Google Scholar 

  43. Costanzo ES, Lutgendorf SK, Mattes ML, et al. (2007) Adjusting to life after treatment for breast cancer. Br J Cancer 97(12): 1625–1631

    PubMed  CAS  Google Scholar 

  44. Coulombe G, Tyldesley S, Speers C, et al. (2007) Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 67(5): 1282–1290

    PubMed  Google Scholar 

  45. Cuzik J (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369(9574): 1711–1723

    Google Scholar 

  46. Danforth DR, Arbogast LK, Friedman CI (2005) Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 83(5): 1333–1338

    PubMed  CAS  Google Scholar 

  47. De Cluze C, Colonna M, Remontet L, et al. (2009) Analysis of the effect of age on the prognosis of breast cancer. Breast Cancer Res Treat 117: 117–119

    Google Scholar 

  48. De la Rochefordiere A, Asselain B, Campana F, et al. (1993) Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039–1043

    PubMed  Google Scholar 

  49. Del Mastro L, Catzeddu T, Boni L, et al. (2006) Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17(1): 74–78

    PubMed  Google Scholar 

  50. Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550–556

    PubMed  CAS  Google Scholar 

  51. Donnez J, Dolmans MM, Demylle D, et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443): 1405–1410

    PubMed  CAS  Google Scholar 

  52. Dunn J, Steginga SK (2000) Young women’s experience of breast cancer: defining young and identifying concerns. Psychooncology 9: 137–146

    PubMed  CAS  Google Scholar 

  53. EBCTCG Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365: 1687–1717

    Google Scholar 

  54. EBCTCG Early Breast Cancer Trialists’ Collaborative Group (2008) Adjuvant chemotherapy in estrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 371: 29–40

    Google Scholar 

  55. Elkhuizen PHM, van de Vijver MJ, Hermans JH, et al. (1998) Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40(4): 859–862

    PubMed  CAS  Google Scholar 

  56. Falk Dahl CA, Reinersten KV, Fossa SD, et al. (2010) A study of body image in long-term breast cancer survivors. Cancer 116(15): 3549–3557

    PubMed  Google Scholar 

  57. Fénichel P, Chevalier N (2011) Existe-t-il des médicaments fertiloprotecteurs en cas de chimiothérapie chez la femme ? Gynecol Obstet Fertil 39(1): 63–66

    PubMed  Google Scholar 

  58. Fernandes-Taylor S, Bloom JR (2010) Post-treatment regret among young breast cancer survivors. Psycho-oncology 2010 Article first published online: 23 APR 2010, DOI:10.1002/pon.1749

  59. Figueiredo J, Ennis M, Knight J, et al. (2007) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 105: 69–80

    PubMed  Google Scholar 

  60. Fischer U, Zachariae O, Baum F, et al. (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14: 1725–1731

    PubMed  Google Scholar 

  61. Fobair P, Steward SL, Chang S, et al. (2006) Body image and sexual problems in young women with breast cancer. Psychooncology 15: 579–594

    PubMed  Google Scholar 

  62. Fobair P, Stewart SL, Chang S, et al. (2009) Body image and sexual problems in young women with breast cancer. Psychooncology 16: 579–594

    Google Scholar 

  63. Foekens JA, Atkins D, Zhang Y, et al. (2006) Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol 24: 1665–1671

    PubMed  CAS  Google Scholar 

  64. Fornier MN, Modi S, Panageas KS, et al. (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104(8): 1575–1579

    PubMed  CAS  Google Scholar 

  65. Fourquet A, Campana F, Zafrani B, et al. (1989) Pronostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17(4): 719–725

    PubMed  CAS  Google Scholar 

  66. Fowble BL, Schultz DJ, Overmoyer B, et al. (1994) The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30(1): 23–33

    PubMed  CAS  Google Scholar 

  67. Ganz P, Greendale GA Petersen L, et al. (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21: 4184–4193

    PubMed  Google Scholar 

  68. Gelber S, Coates AS, Goldhirsch A, et al. (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19: 1671–1675

    PubMed  CAS  Google Scholar 

  69. Gentile M, Bergman Jungestrom M, Olsen KE, et al. (1999) p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation. Eur J Cancer 35: 1202–1207

    PubMed  CAS  Google Scholar 

  70. Gentile M, Olsen K, Dufmats M, et al. (1999) Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival. Br J Cancer 80: 843–849

    PubMed  CAS  Google Scholar 

  71. Gentilini O, Botteri E, Rotmensz N, et al. (2010) Breast-conserving surgery in 201 very young patients (< 35 years). Breast 19: 55–58

    PubMed  Google Scholar 

  72. Gnant M, Mlineritsch B, Stoeger H, et al. (2010) Mature results from ABCSG-12: adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive early breast cancer. 2010 ASCO annual meeting. J Clin Oncol 28: 15s (Suppl.; abstr 533)

    Google Scholar 

  73. Gnerlich J, Deshpande A, Jeffe D, et al. (2008) Elevated breast cancer mortality in young women (< 40 years) compared with older women is attributed to poorer survival in early stage disease. 2008 American College of Surgeons Clinical Congress

  74. Goldhirsch A, Gelber RD, Castiglione M (1990) The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol 1(3): 183–188

    CAS  Google Scholar 

  75. Goldhirsch A, Gelber RD, Yothers G, et al. (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 30: 44–51

    PubMed  Google Scholar 

  76. Goldhirsch A, Ingle JN, Gelber RD, et al. (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20: 1319–1329

    PubMed  CAS  Google Scholar 

  77. Gonzalez-Angulo AM, Timms KM, Liu S, et al. (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res

  78. Goss PE (2009) Outcomes of women who were premenopausal at diagnosis of early stage breast cancer in the NCIC-CTG MA17 Trial. SABCS 2009 Abst 13

  79. Grann VR, Troxel AB, Zojwalla NJ, et al. (2005) Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer 103: 2241–2251

    PubMed  CAS  Google Scholar 

  80. Han HS, Ro J, Lee KS, et al. (2009) Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat 115(2): 335–342

    PubMed  CAS  Google Scholar 

  81. Han W, Kang SY (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer age less than 35 years is a reasonable cut off for defining young age-onset breast cancer. Breast Cancer Res Treat 119(1): 193–200

    PubMed  Google Scholar 

  82. Hankey BF, Miller B, Curtis R, et al. (1994) Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 7-14

  83. Hartley MC, McKinley BP, Rogers EA, et al. (2006) Differential expression of prognostic factors and effect on survival in young (≤ 40) breast cancer patients: a case-control study. Am Surg 72: 1189–1194; discussion 1194–5

    PubMed  Google Scholar 

  84. Hickey M, Peate M, Saunders CM, et al. (2009) Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 15(3): 323–339

    PubMed  CAS  Google Scholar 

  85. Holli K, Isola J (1997) Effect of age on the survival of breast cancer patients. Eur J Cancer 33: 425–428

    PubMed  CAS  Google Scholar 

  86. Hortobagyi GN, Buzdar AU, Marcus CE, et al. (1986) Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr (1): 105–109

  87. Houssami N, Ciatto S, Macaskill P, et al. (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26: 3248–3258

    PubMed  Google Scholar 

  88. IBCSG International Breast Cancer Study Group (2002) Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 94: 1054–1065

    Google Scholar 

  89. Ihemelandu CU, Leffall Jr LD, Dewitty RL, et al. (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143: 109–118

    PubMed  CAS  Google Scholar 

  90. Imai A, Sugiyama M, Furui T, et al. (2007) Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol Obstet Invest 63(2): 102–106

    PubMed  CAS  Google Scholar 

  91. Ives A, Saunders C, Bulsara M, et al. (2007) Pregnancy after breast cancer: population based study. BMJ 334: 194

    PubMed  Google Scholar 

  92. Johnson SM, Shaw JA, Walker RA (2002) Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98: 205–209

    PubMed  CAS  Google Scholar 

  93. Joly F, Espie M, Marty M, et al. (2000) Long-term quality of life in premenopausal women with node negative localized breast cancer with or without adjuvant chemotherapy. Br J Cancer 83: 577–582

    PubMed  CAS  Google Scholar 

  94. Kim J, Kwak B, Lee J, et al. (2007) Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol 14: 3385–3391

    PubMed  Google Scholar 

  95. Knauer M, Mook S, Rutgers EJ, et al. (2010) The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 120: 655–661

    PubMed  CAS  Google Scholar 

  96. Kollias J, Elston CW, Ellis IO, et al. (1997) Early-onset breast cancer. Histopathological and prognostic considerations. Br J Cancer 75: 1318–1323

    PubMed  CAS  Google Scholar 

  97. Kranick JA, Schaefer C, Rowel S (2010) Is pregnancy after breast cancer safe? Breast J 16(4): 404–411

    PubMed  Google Scholar 

  98. Kroman N, Holtveg H, Wohlfahrt J, et al. (2004) Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 100(4): 688–693

    PubMed  Google Scholar 

  99. Kroman N, Jensen M-B, Wohlfahrt J, et al. (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study/Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer. BMJ 320: 474–479

    PubMed  CAS  Google Scholar 

  100. Kroman N, Wohlfahrt J, Andersen KW, et al. (1997) Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 315: 851–855

    PubMed  CAS  Google Scholar 

  101. Krychman ML, King T (2006) Pregnancy after breast cancer: a case study revolving the reproductive challenge with a gestational surrogate. Breast J 12: 363–365

    PubMed  Google Scholar 

  102. Kurtz JM, Jacquemier J, Amalric R, et al. (1990) Why are local recurrences after breast-conservating therapy more frequent in younger patients? J Clin Oncol 8(4): 591–598

    PubMed  CAS  Google Scholar 

  103. Lai H, Lin L, Nadji M, et al. (2002) Mutations in the p53 tumor suppressor gene and early onset breast cancer. Cancer Biol Ther 1: 31–36

    PubMed  CAS  Google Scholar 

  104. Lammers EJR, Huibers P, van der Sangen MJC, et al. (2010) Factors contributing of improved local control after mastectomy in patients with breast cancer aged 40 years or younger. Breast 19: 44–49

    PubMed  Google Scholar 

  105. Largillier R, Savignoni A, Gliogorov J, et al. (2009) Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients ages < 35 years: a GET(N)A Working Group analysis. Cancer 115(22): 5155–5165

    PubMed  Google Scholar 

  106. Lee SJ, Schover LR, Partridge AH, et al. (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. ASCO recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18): 2917–2931

    PubMed  Google Scholar 

  107. Lin CH, Liau JY, Lu YS, et al. (2009) Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev 18: 1807–1814

    PubMed  CAS  Google Scholar 

  108. Malone KE, Daling JR, Doody DR, et al. (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66(16): 8297–8308

    PubMed  CAS  Google Scholar 

  109. Malone KE, Daling JR, Thompson JD, et al. (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279(12): 922–929

    PubMed  CAS  Google Scholar 

  110. Martin M, Pienkowski T, Mackey J, et al. (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352(22): 2302–2313

    PubMed  CAS  Google Scholar 

  111. Martinez-Burgos M, Herrero L, Megías D, et al. (2011) Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil Steril 95(1): 374–377

    PubMed  Google Scholar 

  112. Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, et al. (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21(9): 1675–1681

    PubMed  Google Scholar 

  113. Meirow D, Levron J, Eldar-Geva T, et al. (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353(3): 318–321

    PubMed  CAS  Google Scholar 

  114. Meistrich ML (1994) Failure to demonstrate hormonal protection of chemotherapy-induced fertility reduction in female rats. Reprod Toxicol 8(3): 277–278

    PubMed  CAS  Google Scholar 

  115. Meistrich ML, Shetty G (2008) Hormonal suppression for fertility preservation in males and females. Reproduction 136(6): 691–701

    PubMed  CAS  Google Scholar 

  116. Mignot L, Morvan F, Berdah J, et al. (1986) Pregnancy after treated breast cancer. Results of a case-control study [In French]. Presse Med 15: 1961–1964

    CAS  Google Scholar 

  117. Millikan R, Newman B, Tse C-K, et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123–139

    PubMed  Google Scholar 

  118. Mook S, Schmidt MK, Viale G, et al. (2009) The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat 116: 295–302

    PubMed  CAS  Google Scholar 

  119. Morita Y, Perez GI, Paris F, et al. (2000) Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6(10): 1109–1114

    PubMed  CAS  Google Scholar 

  120. Nixon AJ, Neuberg D, Hayes DF, et al. (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I and II breast cancer. J Clin Oncol 12: 888–894

    PubMed  CAS  Google Scholar 

  121. Nixon AJ, Schnitt SJ, Gelman R, et al. (1996) Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 78(7): 1426–1431

    PubMed  CAS  Google Scholar 

  122. Noyes RD, Spanos WJ Jr, Montague ED (1982) Breast cancer in women aged 30 and under. Cancer 49: 1302–1307

    PubMed  CAS  Google Scholar 

  123. O’Neill SC, Rini C, Goldsmith, et al. (2009) Distress among women receiving uninformative BRCA 1/2 results: 12-month outcomes. Psychooncology 18: 1088–1096

    PubMed  Google Scholar 

  124. Oktay K, Buyuk E, Rodriguez-Wallberg KA, et al. (2010) In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 20(5): 634–638

    PubMed  CAS  Google Scholar 

  125. Oktay K, Buyuk E, Veeck L, et al. (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363(9412): 837–840

    PubMed  Google Scholar 

  126. Oktay K, Cil AP, Bang H (2006) Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 86(1): 70–80

    PubMed  Google Scholar 

  127. Oktay K, Economos K, Kan M, et al. (2001) Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 286(12): 1490–1493

    PubMed  CAS  Google Scholar 

  128. Oktay K, Karlikaya G (2000) Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342(25): 1919

    PubMed  CAS  Google Scholar 

  129. Oktay K, Sönmezer M, Oktem O, et al. (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12(9): 1055–1066

    PubMed  CAS  Google Scholar 

  130. Olivennes F, Aubard Y (2002) Treatment of cancer in women and fertility preservation. Bull Cancer 89(9): 786–794

    PubMed  Google Scholar 

  131. Paik S, Shak S, Tang G, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2826

    PubMed  CAS  Google Scholar 

  132. Paik S, Tang G, Shak S, et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24: 3726–3734

    PubMed  CAS  Google Scholar 

  133. Perez-Fidalgo JA, Roselló S, García-Garré E, et al. (2010) Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat 120(1): 245–251

    PubMed  Google Scholar 

  134. Perou CM, Sorlie T, Eisen MB, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747–752

    PubMed  CAS  Google Scholar 

  135. Pfeiler G (2010) Impact of BMI on endocrine therapy in premenopausal breast cancer patients on analysis of the ABCSG-12 Trial, ASCO 2010

  136. Phipps AI, Buist DS, Malone KE, et al. (2010) Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat

  137. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353: 1659–1672

    PubMed  CAS  Google Scholar 

  138. Querzoli P, Albonico G, di Iasio MG, et al. (2001) Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women. Breast Cancer Res Treat 66: 135–142

    PubMed  CAS  Google Scholar 

  139. Recchia F, Saggio G, Amiconi G, et al. (2006) Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106(3): 514–523

    PubMed  CAS  Google Scholar 

  140. Regan MM, Pagani O, Walley B, et al. (2008) Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol 19: 1231–1241

    PubMed  CAS  Google Scholar 

  141. Reh A, Oktem O, Oktay K (2008) Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 90(5): 1635–1639

    PubMed  CAS  Google Scholar 

  142. Ries L, Melbert D, Krapcho M, et al. (2008) SEER Cancer Statistics Review, 1975–2005. National cancer Institute; Bethesda, MD: http://seercancergov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER website

    Google Scholar 

  143. Rosen PP, Lesser ML, Kinne DW, Beattie EJ (1984) Breast carcinoma in women 35 years of age or younger. Ann Surg 199(2): 133–142

    PubMed  CAS  Google Scholar 

  144. Rosendahl M, Loft A, Byskov AG, et al. (2006) Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod 21(8): 2006–2009

    PubMed  CAS  Google Scholar 

  145. Roux C, Amiot C, Agnani G, et al. (2010) Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril 93(7): 2413 e15–e19

    PubMed  Google Scholar 

  146. Rouzier R, Perou CM, Symmans WF, et al. (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11: 5678–5685

    PubMed  CAS  Google Scholar 

  147. Salumets A, Suikkari AM, Mäkinen S, et al. (2006) Frozen embryo transfers: implications of clinical and embryological factors on the pregnancy outcome. Hum Reprod 21(9): 2368–2374

    PubMed  Google Scholar 

  148. Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect“. Am J Obstet Gynecol 170: 818–823

    PubMed  CAS  Google Scholar 

  149. Schmitt SJ, Abner A, Gelman R, et al. (1994) The relation-ship between microscopic margins of resection and the risk of local recurrence in patients with breast-conserving surgery and radiation therapy. Cancer 74: 1746–751

    Google Scholar 

  150. Schover LR, Rybicki LA, Martin BA, et al. (1999) Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer 86(4): 697–709

    PubMed  CAS  Google Scholar 

  151. SFSPM (2004) Grossesse après cancer du sein. In: F. Abel-Decollogne, A. Lessur, N. Mallol, M. Mugnoz (eds) 26e Journée de la SFSPM, 6 novembre 2004

  152. Shalom-Paz E, Almog B, Shehata F, et al. (2010) Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online 21(4): 566–571

    PubMed  Google Scholar 

  153. Siegel K, Gluhoski V, Gorey E (1999) Age-related distress among young women with breast cancer. J Psychosoc Oncol 17(1): 1–20

    Google Scholar 

  154. Solin LJ, Orel SG, Hwang WT, et al. (2008) Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26: 386–391

    PubMed  Google Scholar 

  155. Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11(5): 422–434

    PubMed  CAS  Google Scholar 

  156. Sorlie T, Perou CM, Tibshirani R, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869–10874

    PubMed  CAS  Google Scholar 

  157. Sorlie T, Tibshirani R, Parker J, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418–8423

    PubMed  CAS  Google Scholar 

  158. Sotiriou C, Wirapati P, Loi S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262–272

    PubMed  CAS  Google Scholar 

  159. Spica L, Bendiane MK, Perretti-Wattell P, et al. (2010) L’expérience de la douleur parmi des femmes atteintes d’un cancer du sein (cohorte Ellipse). Bull Cancer 97: 909–916

    PubMed  CAS  Google Scholar 

  160. Swain SM, Land SR, Ritter MW, et al. (2009) Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 113(2): 315–320

    PubMed  CAS  Google Scholar 

  161. Tham YL, Sexton K, Weiss H, et al. (2007) The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 30(2): 126–132

    PubMed  CAS  Google Scholar 

  162. Thewes B, Meiser B, Rickard J, et al. (2003) The fertility-and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology 12(5): 500–511

    PubMed  Google Scholar 

  163. Thürlimann B, Price KN, Gelber RD, et al. (2009) Is chemotherapy necessary for premenopausal women with lower-risk node positive, endocrine responsive breast cancer? 10-Year update of International Breast Cancer Study Group Trial 11-93. Breast Cancer Res Treat 113: 137–144

    PubMed  Google Scholar 

  164. Touboul E, Buffat L, Belkacémi Y, et al. (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43(1): 25–38

    PubMed  CAS  Google Scholar 

  165. Turnbull L, Brown S, Harvey I, et al. (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375: 563–571

    PubMed  Google Scholar 

  166. Van den Hurk CJ, Mols F, Vingerhoets A, et al. (2010) Impact of alopecia and scalp cooling on the well being of breast cancer patients. Psychooncology 19: 701–709

    PubMed  Google Scholar 

  167. Van der Leest M, Evers L, van der Sangen MJC, et al. (2007) The safety of breast-conserving therapy in patients with breast cancer aged ≤ 40 years. Cancer 109: 1957–1964

    PubMed  Google Scholar 

  168. Van der Sangen MJC, Van de Wiel FMM, Poortmans PMP, et al. (2010) Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years. Breast Cancer Res Treat 1127: 207–215

    PubMed  Google Scholar 

  169. van Dongen JA, Voogd AC, Fentiman IS, et al. (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92(14): 1143–1150

    PubMed  Google Scholar 

  170. van’t Veer LJ, Dai H, van de Vijver MJ, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536

    Google Scholar 

  171. Varga D, Koenig J, Kuhr K, et al. (2010) Comparison of early onset breast cancer patients to older premenopausal breast cancer patients. Arch Gynecol Obstet 282: 427–432

    PubMed  Google Scholar 

  172. Velentgas P, Daling JR, Malone KE, et al. (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85: 2424–2432

    PubMed  CAS  Google Scholar 

  173. Vincini F, Recht A, Abner A, et al. (1990) The association between very young age and recurrence in the breast in PTS treated with conservative surgery (CS) and radiation therapy (RT). Int J Radiat Oncol Biolog Physics 19(Suppl 1): 132

    Google Scholar 

  174. Von Schoultz E, Johansson H, Wilking N, et al. (1995) Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13: 430–434

    Google Scholar 

  175. Voogd AC, Nielsen M, Peterse JL, et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European Randomized Trials. JCO 19(6): 1688–1697

    CAS  Google Scholar 

  176. Vrieling C, Collette L, Fourquet A, et al. (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55(3): 219–232

    PubMed  CAS  Google Scholar 

  177. Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occuring in young women (< 35 years) are different. Br J Cancer 74: 1796–1800

    PubMed  CAS  Google Scholar 

  178. Wang Y, Klijn JG, Zhang Y, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679

    PubMed  CAS  Google Scholar 

  179. Weber-Mangal S, Sinn HP, Popp S, et al. (2003) Breast cancer in young women (≤ 35 years): genomic aberrations detected by comparative genomic hybridization. Int J Cancer 1107: 583–592

    PubMed  CAS  Google Scholar 

  180. Weiss J, Poppelreuter M, Bartsch H (2009) Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: ’subjective’ complaints and ‘objective’ neuropsychological test results. Psychooncology 1818: 775–778

    Google Scholar 

  181. Werkoff G, Morel O, Malartic C, et al. (2008) Pregnancy after breast cancer: the obstetricians’ point of view. Literature review. Gynecol Obstet Fertil 36(10): 1022–1029

    CAS  Google Scholar 

  182. Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78: 1838–1843

    PubMed  CAS  Google Scholar 

  183. Wong-Kim EC, Bloom JR (2005) Depression experienced by young women newly diagnosed with breast cancer. Psychooncology 14: 564–573

    PubMed  Google Scholar 

  184. Zebrack B (2009) Information and service needs for young adult cancer survivors. Support Care Cancer 17: 349–357

    PubMed  Google Scholar 

  185. Zhou P, Gautam S, Recht A (2007) Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 101: 51–57

    PubMed  CAS  Google Scholar 

  186. Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 18(7):1307–1318

    PubMed  CAS  Google Scholar 

Références électroniques

  1. HAS 2010. Place de l’IRM mammaire dans le bilan d’extension locorégional préthérapeutique du cancer du sein. Haute Autorité de santé, mars 2010. www.has-sante.fr

  2. INCa 2010. Recommandations de l’INCa: chirurgie prophylactique des cancers avec prédisposition génétique “www.e-cancer.fr“ “http://www.e-cancer.fr/soins/recommandations/oncogenetique”

Download references

Authors
  1. M. -P. Chauvet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Debled
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Decanter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Goncalves
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Largillier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Pujol
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Saltel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Taourel
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Chauvet, M.P., Debled, M., Decanter, C. et al. Prise en charge du cancer du sein infiltrant de la femme âgée de 40 ans ou moins. Oncologie 13, 703–726 (2011). https://doi.org/10.1007/s10269-011-2078-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-011-2078-9

Search

Navigation